An Act Relating to Orally Administered Cancer Therapy
Maine Legislature, Session 126, LD 0627
Committee: Insurance and Financial Services
Sponsors: CAIN, HOBBINS, ALFOND, CRAVEN, CUSHING, GRATWICK, McCABE, POULIOT
Amends: 24 MRSA §2320-H, 24-A MRSA §2745-H, 24-A MRSA §2837-I, 24-A MRSA §4234-F

Legislative Document 
No. 627 
S.P. 217 
In Senate, February 21, 2013 
An Act Relating to Orally Administered Cancer Therapy 
Reference to the Committee on Insurance and Financial Services suggested and ordered 
printed. 
DAREK M. GRANT 
Secretary of the Senate 
Presented by Senator CAIN of Penobscot. 
Cosponsored by Representative HOBBINS of Saco and 
Senators: President ALFOND of Cumberland, CRAVEN of Androscoggin, CUSHING of 
Penobscot, GRATWICK of Penobscot, Representatives: McCABE of Skowhegan, POULIOT 
of Augusta. 
Be it enacted by the People of the State of Maine as follows: 
Sec. 1.  24 MRSA §2320-H is enacted to read: 
§2320-H.  Orally administered cancer therapy 
All individual and group nonprofit hospital and medical services plan policies, 
contracts and certificates and all nonprofit health care plan policies, contracts and 
certificates that provide coverage for cancer chemotherapy treatment must provide 
coverage for prescribed, orally administered anticancer medications used to kill or slow 
the growth of cancerous cells that is equivalent to the coverage provided for 
intravenously administered or injected anticancer medications.  An increase in patient 
cost sharing for anticancer medications may not be used to achieve compliance with this 
section. 
Sec. 2.  24-A MRSA §2745-H is enacted to read: 
§2745-H.  Orally administered cancer therapy 
All individual insurance policies, contracts and certificates that provide coverage for 
cancer chemotherapy treatment must provide coverage for prescribed, orally administered 
anticancer medications used to kill or slow the growth of cancerous cells that is 
equivalent to the coverage provided for intravenously administered or injected anticancer 
medications.  An increase in patient cost sharing for anticancer medications may not be 
used to achieve compliance with this section. 
Sec. 3.  24-A MRSA §2837-I is enacted to read: 
§2837-I.  Orally administered cancer therapy 
All group insurance policies, contracts and certificates that provide coverage for 
cancer chemotherapy treatment must provide coverage for prescribed, orally administered 
anticancer medications used to kill or slow the growth of cancerous cells that is 
equivalent to the coverage provided for intravenously administered or injected anticancer 
medications.  An increase in patient cost sharing for anticancer medications may not be 
used to achieve compliance with this section. 
Sec. 4.  24-A MRSA §4234-F is enacted to read: 
§4234-F.  Orally administered cancer therapy 
All individual and group health maintenance organization policies, contracts and 
certificates that provide coverage for cancer chemotherapy treatment must provide 
coverage for prescribed, orally administered anticancer medications used to kill or slow 
the growth of cancerous cells that is equivalent to the coverage provided for 
intravenously administered or injected anticancer medications.  An increase in patient 
cost sharing for anticancer medications may not be used to achieve compliance with this 
section. 
Sec. 5.  Application.  This Act applies to all policies, contracts and certificates 
executed, delivered, issued for delivery, continued or renewed in this State on or after 
October 1, 2013.  For purposes of this Act, all contracts are deemed to be renewed no 
later than the next yearly anniversary of the contract date. 
SUMMARY 
This bill requires health insurance policies that cover cancer chemotherapy to include 
coverage for orally administered anticancer medications.